Skip to main content

Advertisement

Log in

Remifentanil and glucose suppress inflammation in a rat model of surgical stress

  • Original Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Purpose

Postoperative stress produces an inflammatory response. Recent studies have shown that narcotic analgesics suppress the immune system. Nutritional management during perioperative care has also been reported to affect inflammation. We therefore examined whether remifentanil or glucose administration could ameliorate postsurgical inflammatory responses using a rat model of surgical stress.

Methods

We divided male Wistar rats randomly into five groups: (1) control, (2) sevoflurane+lactated Ringer’s solution, (3) sevoflurane+lactated Ringer’s solution with 1% glucose, (4) sevoflurane+remifentanil+lactated Ringer’s solution, and (5) sevoflurane+remifentanil+ lactated Ringer’s solution with 1% glucose. In all groups, serum samples were obtained at various time points after surgery, and secreted cytokine concentrations were determined. In addition, we assessed the activation of protein kinase B (Akt) and forkhead/winged helix box class O (FOXO3), which play a role in gluconeogenesis/stress responses.

Results

Surgical stress increased the serum concentrations of tumor necrosis factor-α and interleukin-6. Groups receiving remifentanil with anesthesia showed an attenuated inflammatory response. The inflammatory response was also reduced by administering 1% glucose. Furthermore, 1% glucose induced Akt and FOXO3 phosphorylation in the quadriceps femoris muscle 12 h after surgery.

Conclusions

Anesthesia based on remifentanil and perioperative administration of lactated Ringer’s solution containing 1% glucose may be able to control inflammatory responses caused by surgical stress.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Patrick DA, Moore FA, Moore EE, Biffi WL, Sauaia A, Barnett CC. The inflammatory profile of interleukin-6, interleukin-8, and soluble intercellular adhesion molecule-1 in postinjury multiple organ failure. Am J Surg 1996;172:425–431.

    Article  Google Scholar 

  2. Wong GT, Li R, Jiang LL, Irwin MG. Remifentanil post-conditioning attenuates cardiac ischemia-reperfusion injury via kappa or delta opioid receptor activation. Acta Anaesthesiol Scand 2010;54:510–518.

    Article  PubMed  CAS  Google Scholar 

  3. Kim HS, Cho JE, Hong SW, Kim SO, Shim JK, Kwak YL. Remifentanil protects myocardium through activation of anti-apoptotic pathways of survival in ischemia-reperfused rat heart. Physiol Res 2010;59:347–356.

    PubMed  CAS  Google Scholar 

  4. Bencsics A, Elenkov IJ, Vizi ES. Effect of morphine on lipopolysaccharide-induced tumor necrosis factor-production in vivo: involvement of the sympathetic nervous system. J Neuroimmunol 1997;73:1–6.

    Article  PubMed  CAS  Google Scholar 

  5. Murphy GS, Szokol JW, Marymont JH, Avram MJ, Vender JS. The effects of morphine and fentanyl on the inflammatory response to cardiopulmonary bypass in patients undergoing elective coronary artery bypass graft surgery. Anesth Analg 2007;104:1334–1342.

    Article  PubMed  CAS  Google Scholar 

  6. Crossland H, Constantin-Teodosiu D, Gardiner SM, Constantin D, Greenhaff PL. A potential role for Akt/FOXO signalling in both protein loss and the impairment of muscle carbohydrate oxidation during sepsis in rodent skeletal muscle. J Physiol 2008;586:5589–5600.

    Article  PubMed  CAS  Google Scholar 

  7. Bezzi M, Hasmim M, Bieler G, Dormond O, Ruegg C. Zoledronate sensitizes endothelial cells to tumor necrosis factor-induced programmed cell death: evidence for the suppression of sustained activation of focal adhesion kinase and protein kinase B/Akt. J Biol Chem 2003;278:43603–43614.

    Article  PubMed  CAS  Google Scholar 

  8. Lin L, Hron JD, Peng SL. Regulation of NF-kappaB, Th activation, and autoinflammation by the forkhead transcription factor Foxo3a. Immunity 2004;21:203–213.

    Article  PubMed  CAS  Google Scholar 

  9. Tremblay ML, Giguère V. Phosphatases at the heart of FoxO metabolic control. Cell Metab 2008;7:101–103.

    Article  PubMed  CAS  Google Scholar 

  10. Baigrie RJ, Lamont P, Dallman MJ, Kwiatkowski D, Morris PJ. The cytokine response to major surgery. Br J Surg 1992;79:757–760.

    Article  PubMed  CAS  Google Scholar 

  11. Ohzato H, Yoshizaki K, Nishimoto N, Ogata A, Tagoh H, Monden M, et al. Interleukin-6 is a new indicator of inflammatory status: detection of serum levels of interleukin-6 and C-reactive protein after surgery. Surgery 1992;111:201–209.

    PubMed  CAS  Google Scholar 

  12. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359–1367.

    Article  PubMed  Google Scholar 

  13. Guha M, Bai W, Nadler JL, Natarajan R. Molecular mechanisms of tumor necrosis factor alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways. J Biol Chem 2000;275:17728–17739.

    Article  PubMed  CAS  Google Scholar 

  14. Hagiwara S, Iwasaka H, Hasegawa A, Koga H, Noguchi T. Effects of hyperglycemia and insulin therapy on high mobility group box 1 in endotoxin-induced acute lung injury in a rat model. Crit Care Med 2008;36:2407–2413.

    Article  PubMed  CAS  Google Scholar 

  15. Tanaka T, Nabatame H, Tanifuji Y. Insulin secretion and glucose utilization are impaired under general anesthesia with sevoflurane as well as isoflurane in a concentration-independent manner. J Anesth 2005;19:277–281.

    Article  PubMed  Google Scholar 

  16. Saho S, Kadota Y, Sameshima T, Miyao J, Tsurumaru T, Yoshimura N. The effects of sevoflurane anesthesia on insulin secretion and glucose metabolism in pigs. Anesth Analg 1997;84:1359–1365.

    PubMed  CAS  Google Scholar 

  17. Bonnet MP, Beloeil H, Benhamou D, Mazoit JX, Asehnoune K. The mu opioid receptor mediates morphine-induced tumor necrosis factor and interleukin-6 inhibition in toll-like receptor 2-stimulated monocytes. Anesth Analg 2008;106:1142–1149.

    Article  PubMed  CAS  Google Scholar 

  18. Farese RV. Insulin-sensitive phospholipid signaling systems and glucose transport. Update II. Exp Biol Med (Maywood) 2001;226:283–295.

    CAS  Google Scholar 

  19. Farese RV, Sajan MP, Standaert ML. Insulin-sensitive protein kinases (atypical protein kinase C and protein kinase B/Akt): actions and defects in obesity and type II diabetes. Exp Biol Med 2005;230:593–605.

    CAS  Google Scholar 

  20. Stephens L, Anderson K, Stokoe D, Erdjument-Bromage H, Painter GF, Holmes AB, et al. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science 1998;279:710–714.

    Article  PubMed  CAS  Google Scholar 

  21. Myatt SS, Lam EW. The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer 2007;7:847–859.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hasegawa, A., Iwasaka, H., Hagiwara, S. et al. Remifentanil and glucose suppress inflammation in a rat model of surgical stress. Surg Today 41, 1617–1621 (2011). https://doi.org/10.1007/s00595-010-4457-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-010-4457-z

Key words

Navigation